ComMedica Secures Further Backing

  • 21 August 2002

ComMedica Limited, an innovative web-based clinical information system company spun-out from London’s Imperial College, has secured a further £2 million in funding.

The money will be used to continue development of ComMedica’s Patient Record Library System, or PiRiLiS, a unique system that allows complete patient medical records, including still and moving images, to be accessed from any web browser.

The funding round includes £250,000 from NPI Ventures Limited, a technology investment firm set up by Nikko Principal Investments Limited (NPIL) to invest in Imperial College spin-out companies. Private investors are contributing the balance of the finance.

ComMedica’s Chief Executive Officer, Mark Simon, said the extra investment will be invested in PiRiLiS. “This new funding comes at an exciting time for ComMedica as our PiRiLiS technology is really causing the healthcare market to sit up and take notice."

He added that the PiRiLiS system offered an essential component of the NHS’s new model of an Integrated Care Record Service (ICRS).

Simon Oakland, director of NPI Ventures and a Principal from NPIL, said: “ComMedica has a ground-breaking product and an exciting opportunity, and we are delighted to be able to support the next phase in its development.”

NPI Ventures will become observers on the ComMedica board, joining Imperial College, the founder members of ComMedica, and the executive directors.

ComMedica is an offshoot of London University’s Imperial College of Science, Technology and Medicine. It was officially formed in June 1999 to commercialise an electronic patient information environment.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Digital Health Networks 2024 mentoring scheme celebrated

Digital Health Networks 2024 mentoring scheme celebrated

The Digital Health Networks' 2024 mentoring programme has received positive feedback, ahead of the expanded 2025 programme launch.
Digital Health Coffee Time Briefing ☕ 

Digital Health Coffee Time Briefing ☕ 

The 100th edition includes the launch of a new health tech accelerator and research showing the microbiome can identify who might benefit from immunotherapy
Qure.ai AI collaborative trial is underway to speed up lung cancer diagnosis

Qure.ai AI collaborative trial is underway to speed up lung cancer diagnosis

A collaborative trial from Qure.ai, UK academia and two NHS trusts is aiming to improve the speed of a lung cancer diagnosis using artificial intelligence.